Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: A randomized multicenter trial (LIR!C-trial)

BMC Surgery

Volumn 8, Issue , 2008, Pages

  Eshuis, Emma J ^a   Bemelman, Willem A ^a   Van Bodegraven, Ad A ^b   Sprangers, Mirjam A G ^a   Bossuyt, Patrick M M ^a   De Wit, A W Marc Van Milligen ^c   Crolla, Rogier M P H ^c   Cahen, Djuna L ^d   Oostenbrug, Liekele E ^e   Sosef, Meindert N ^e   Voorburg, Annet M C J ^f   Davids, Paul H P ^f   Van Der Woude, C Janneke ^g   Lange, Johan ^g   Mallant, Rosalie C ^h   Boom, Maarten J ^h   Lieverse, Rob J ⁱ   Van Der Zaag, Edwin S ⁱ   Houben, Martin H M G ^j   Vecht, Juda ^k   Pierik, Robert E G J M ^k   Van Ditzhuijsen, Theo J M ^l   Prins, Hubert A ^l   Marsman, Willem A ^m   Stockmann, Henricus B ^m   Brink, Menno A ⁿ   Consten, Esther C J ⁿ   Van Der Werf, Sjoerd D J ^o   Marinelli, Andreas W K S ^o   Jansen, Jeroen M ^m   Gerhards, Michael F ^m   Bolwerk, Clemens J M ^m   Stassen, Laurents P S ^m   Spanier, B W Marcel ^p   Bilgen, Ernst Jan Spillenaar ^p   Van Berkel, Anne Marie ^q   Cense, Huib A ^q   Van Heukelem, Henk A ^r   Van De Laar, Arnold ^r   Slot, Warner Bruins ^s   Eijsbouts, Quirijn A ^s   Van Ooteghem, Nancy A M ^t   Van Wagensveld, Bart ^t   Van Den Brande, Jan M H ^u   Van Geloven, Anna A W ^u   Bruin, Karien F ^v   Maring, John K ^v   Oldenburg, Bas ^w   Van Hillegersberg, Richard ^w   De Jong, Dirk J ^x   Bleichrodt, Robert ^x   Van Der Peet, Donald L ^b   Dekkers, Pascal E P ^y   Goei, T Hauwy ^y   Stokkers, Pieter C F ^a   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

^d AMSTELLAND HOSPITAL   (Netherlands)

^e Sittard Geleen Heerlen   (Netherlands)

^f DEPARTMENT OF SURGERY   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h Flevo Hospital   (Netherlands)

ⁱ GELRE HOSPITALS   (Netherlands)

^j HAGA HOSPITAL   (Netherlands)

^k ISALA HOSPITAL   (Netherlands)

^l JEROEN BOSCH HOSPITAL   (Netherlands)

^m Kennemer Gasthuis ^*  (Netherlands)

ⁿ MEANDER MEDICAL CENTER   (Netherlands)

^o MEDICAL CENTER HAAGLANDEN   (Netherlands)

^p RIJNSTATE HOSPITAL   (Netherlands)

^q RED CROSS HOSPITAL   (Netherlands)

^r SLOTERVAART HOSPITAL   (Netherlands)

^s Infection and Immunology   (Netherlands)

^t ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^u Tergooi Hospitals   (Netherlands)

^v CPRLab   (Netherlands)

^w UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^x RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^y ZAANS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CLEMASTINE; IMMUNOMODULATING AGENT; INFLIXIMAB; LIVER ENZYME; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; STEROID; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; ECONOMIC EVALUATION; ENTERITIS; HOSPITALIZATION; HUMAN; ILEITIS; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; TREATMENT OUTCOME; COLON; ECONOMICS; ILEUM; LAPAROSCOPY;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COLON; CROHN DISEASE; HUMANS; ILEUM; LAPAROSCOPY; QUALITY OF LIFE; RECURRENCE;

EID: 51749121583     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-8-15     Document Type: Article

References (29)

1. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. SB Hanauer, Inflamm Bowel Dis 2006 12 Suppl 1 S3 S9 16378007 10.1097/01.MIB.0000195385.19268.68
2. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. F Baert M Noman S Vermeire AG Van HG D' A Carbonez P Rutgeerts, N Engl J Med 2003 348 601 608 12584368 10.1056/NEJMoa020888
3. Optimizing anti-TNF treatment in inflammatory bowel disease. P Rutgeerts AG Van S Vermeire, Gastroenterology 2004 126 1593 1610 15168370 10.1053/j.gastro.2004.02.070
4. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. SP Travis EF Stange M Lemann T Oresland Y Chowers A Forbes G D'Haens G Kitis A Cortot C Prantera P Marteau JF Colombel P Gionchetti Y Bouhnik E Tiret J Kroesen M Starlinger NJ Mortensen, Gut 2006 55 Suppl 1 i16 i35 16481629 10.1136/gut.2005.081950b
5. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. EF Stange SP Travis S Vermeire C Beglinger L Kupcinkas K Geboes A Barakauskiene V Villanacci HA Von BF Warren C Gasche H Tilg SW Schreiber J Scholmerich W Reinisch, Gut 2006 55 Suppl 1 i1 15 16481628 10.1136/gut.2005.081950a
6. Long-Term Surgical Recurrence, Morbidity, Quality of Life, and Body Image of Laparoscopic-Assisted vs. Open Ileocolic Resection for Crohn's Disease: A Comparative Study. EJ Eshuis SW Polle JF Slors DW Hommes MA Sprangers DJ Gouma WA Bemelman, Dis Colon Rectum 2008 18266036
7. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn's disease compared with conventional surgery? A long-term, follow-up study. JK Lowney DW Dietz EH Birnbaum IJ Kodner MG Mutch JW Fleshman, Dis Colon Rectum 2006 49 58 63 16328612 10.1007/s10350-005-0214-6
8. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. T Bernklev J Jahnsen T Schulz J Sauar I Lygren M Henriksen N Stray O Kjellevold E Aadland M Vatn B Moum, Eur J Gastroenterol Hepatol 2005 17 1037 1045 16148548 10.1097/00042737-200510000-00006
9. Quality of life in inflammatory bowel disease. JR Love EJ Irvine RN Fedorak, J Clin Gastroenterol 1992 14 15 19 1556402 10.1097/00004836-199201000- 00005
10. Quality of life improves within 30 days of surgery for Crohn's disease. CP Delaney RP Kiran AJ Senagore B O'Brien-Ermlich J Church TL Hull FH Remzi VW Fazio, J Am Coll Surg 2003 196 714 721 12742203 10.1016/S1072-7515(03)00131-5
11. Advantages of laparoscopic resection for ileocecal Crohn's disease. HJ Duepree AJ Senagore CP Delaney KM Brady VW Fazio, Dis Colon Rectum 2002 45 605 610 12004208 10.1007/s10350-004-6253-6
12. Cosmesis and body image after laparoscopic-assisted and open ileocolic resection for Crohn's disease. MS Dunker AM Stiggelbout RA van Hogezand J Ringers G Griffioen WA Bemelman, Surg Endosc 1998 12 1334 1340 9788857 10.1007/s004649900851
13. Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial. S Maartense MS Dunker JF Slors MA Cuesta EG Pierik DJ Gouma DW Hommes MA Sprangers WA Bemelman, Ann Surg 2006 243 143 149 16432345 10.1097/01.sla.0000197318.37459.ec
14. Short-Term Outcomes after Laparoscopic Ileocolic Resection for Crohn's Disease. A Systematic Review. SW Polle J Wind DT Ubbink DW Hommes DJ Gouma WA Bemelman, Dig Surg 2006 23 346 357 17164582 10.1159/000097950
15. Advantages of laparoscopic resection for ileocolic Crohn's disease. Improved outcomes and reduced costs. TM Young-Fadok K HallLong EJ McConnell RG Gomez RL Cabanela, Surg Endosc 2001 15 450 454 11353959 10.1007/s004640080078
16. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. NK Aaronson M Muller PD Cohen ML Essink-Bot M Fekkes R Sanderman MA Sprangers VA te E Verrips, J Clin Epidemiol 1998 51 1055 1068 9817123 10.1016/S0895-4356(98)00097- 3
17. Euroqol: a new facility for the measurement of health-related quality of life. EQ Group, Health Policy 1990 199 208 10109801
18. A new measure of health status for clinical trials in inflammatory bowel disease. G Guyatt A Mitchell EJ Irvine J Singer N Williams R Goodacre C Tompkins, Gastroenterology 1989 96 804 810 2644154
19. Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. HH Konig A Ulshofer M Gregor TC Von M Reinshagen G Adler R Leidl, Eur J Gastroenterol Hepatol 2002 14 1205 1215 12439115 10.1097/00042737- 200211000-00008
20. The inflammatory bowel disease questionnaire: a review of its national validation studies. AG Pallis IA Mouzas IG Vlachonikolis, Inflamm Bowel Dis 2004 10 261 269 15290922 10.1097/00054725-200405000-00014
21. J Cohen, Statitical Power Anlyses for the Behavioral Sciences. Mahwah, Associates NJIE, 1988
22. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. GR Norman JA Sloan KW Wyrwich, Med Care 2003 41 582 592 12719681 10.1097/00005650-200305000-00004
23. Guidelines for treatment with infliximab for Crohn's disease. DW Hommes B Oldenburg AA van Bodegraven RA van Hogezand DJ de Jong MJ Romberg-Camps WJ van der G Dijkstra, Neth J Med 2006 64 219 229 16929083
24. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. JF Colombel WJ Sandborn P Rutgeerts R Enns SB Hanauer R Panaccione S Schreiber D Byczkowski J Li JD Kent PF Pollack, Gastroenterology 2007 132 52 65 17241859 10.1053/j.gastro.2006.11.041
25. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. SB Hanauer WJ Sandborn P Rutgeerts RN Fedorak M Lukas D MacIntosh R Panaccione D Wolf P Pollack, Gastroenterology 2006 130 323 333 16472588 10.1053/j.gastro.2005.11.030
26. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. WJ Sandborn P Rutgeerts R Enns SB Hanauer JF Colombel R Panaccione G D'Haens J Li MR Rosenfeld JD Kent PF Pollack, Ann Intern Med 2007 146 829 838 17470824
27. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. WJ Sandborn SB Hanauer P Rutgeerts RN Fedorak M Lukas DG MacIntosh R Panaccione D Wolf JD Kent B Bittle J Li PF Pollack, Gut 2007 56 1232 1239 17299059 10.1136/gut.2006.106781
28. Certolizumab pegol for the treatment of Crohn's disease. WJ Sandborn BG Feagan S Stoinov PJ Honiball P Rutgeerts D Mason R Bloomfield S Schreiber, N Engl J Med 2007 357 228 238 17634458 10.1056/NEJMoa067594
29. Maintenance therapy with certolizumab pegol for Crohn's disease. S Schreiber M Khaliq-Kareemi IC Lawrance OO Thomsen SB Hanauer J McColm R Bloomfield WJ Sandborn, N Engl J Med 2007 357 239 250 17634459 10.1056/NEJMoa062897